CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

MINOCA: a heterogenous group of conditions associated with myocardial damage Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel Mechanisms of Vascular Aging, A Geroscience Perspective JACC Focus Seminar Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease: Mendelian Randomization Investigation The contribution of tissue-grouped BMI-associated gene sets to cardiometabolic-disease risk: a Mendelian randomization study Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications

LetterJune 2, 2020 Vol 141, Issue 22

JOURNAL:Circulation. Article Link

Lipoprotein(a) in Alzheimer, Atherosclerotic, Cerebrovascular, Thrombotic, and Valvular Disease: Mendelian Randomization Investigation

SC Larsson, D Gill , AM Mason et al. Keywords: Lipoprotein(a); causal effect; CAD; valvular disease

Full Text PDF